A world without antibiotics? The risk is real, experts say

by Mariette Le Roux

Humans face the very real risk of a future without antibiotics, a world of plummeting life expectancy where people die from diseases easily treatable today, scientists say.

Experts tracking the rise of say years of health gains could be rolled back by mutating microbes that make illnesses more difficult and expensive to cure and carry a higher risk of death.

Some say the threat to wellbeing is on the scale of global warming or terrorism—yet resistance is being allowed to spread through an entirely preventable means— improper use of antibiotics.

"It is a major public health problem," Patrice Courvalin, who heads the Antibacterial Agents Unit of France's Pasteur Institute, told AFP.

"It is about more than not being able to treat a disease. It will erase much progress made in the last 20-30 years."

Without antibiotics to tackle opportunistic bacteria that pose a particular risk for people who are very ill, major surgery, organ transplants or cancer and leukaemia treatment may become impossible, he explained.

"In some parts of the world, already we have run out of antibiotics," said Timothy Walsh, a professor of medical microbiology at Cardiff University.

"In places in India, Pakistan, Bangladesh, possibly Russia, Southeast Asia, central South America, we are at the end game. There's nothing left. And unfortunately there is nothing in the pipeline either."

Resistance to drugs emerges through changes in the bacterium's genetic code—altering the target on its surface to which antibiotics would normally bind, making the germ impenetrable or allowing it to destroy or "spit out" the antibiotic.

These super-germs triumph through Darwinian pressure, helped by humans.

The wrong antibiotics, taken for too short a period, in too low a dose or stopped to early, will fail to kill the altered microbes.

Instead, the drugs will indiscriminately damage other bacteria and give the resistant strain a competitive advantage—allowing it to dominate and spread.

At the base of the problem is doctors prescribing antibiotics wrongly or unnecessarily, and the ease with which medicines can be obtained without a script in some parts of the world, including Asia and Africa.

As much as 70 percent of antibiotics are given for viral infections, against which they are wholly ineffective, the experts say.

Then there is the problem of farmers in countries like the United States adding antibiotics to animal feed to help herds grow faster.

Compounding all of this is the rise in global travel—a boon for bacterial spread, and a sharp drop in antibiotics development blamed on a lack of financial incentives for the pharmaceutical industry.

A return to the pre-antibiotic era?

The World Health Organisation (WHO) says drug resistance "threatens a return to the pre-antibiotic era".

"Many infectious diseases risk becoming untreatable or uncontrollable," it states in a factsheet on antimicrobial resistance.

A case in point: some 450 000 people developed multi-drug resistant (MDR) TB in 2012 and 170,000 died from it. MDR TB does not respond to the most potent TB drugs—isoniazid and rifampin.

Nearly 10 percent of MDR cases are thought to be of the even deadlier XDR (extensively drug resistant) variety which does not respond to a yet wider range of drugs.

Like other drug-resistant microbes, MDR and XDR TB can be transferred directly between people—you can get it even if you have never taken antibiotics in your life.

"Antibiotic resistance is an emerging disease and a societal problem. The use you can make of an antibiotic depends on the use made by others," said Courvalin.

Another worry for health planners today is the spread of a multi-drug resistant strain of the bacterium Klebsiella pneumoniae—a common cause of infections of the urinary tract, respiratory tract and bloodstream, and a frequent source of hospital outbreaks.

In some parts of the world, only the carbapenem antibiotics class remains effective, but now signs are emerging of resistance even to this last line of defence.

Antibiotics are thought to have saved hundreds of millions of lives since Alexander Fleming first discovered penicillin in 1928.

But even Fleming's own warnings of impending drug resistance went unheeded, and now scientists say people may start dying from infections like meningitis and septicaemia that are eminently curable today.

"If we keep going like this, the vast majority of human bacterial pathogens will be multi-resistant to antibiotics," said Courvalin.

The answer? Prudent drug use—better and faster diagnosis to determine whether an infection is viral or bacterial and whether it is even susceptible to treatment.

Farmers must stop feeding to their livestock, and hospital and individuals improve their hygiene to prevent bacterial spread.

Yet few experts believe the damage can be undone.

"The bugs have become very sophisticated, they've become very complex," said Walsh.

"You can decrease resistance or reduce it, but never completely reverse it."

add to favorites email to friend print save as pdf

Related Stories

Antibiotics – friend and foe?

Nov 18, 2013

European Antibiotic Awareness Day is marked on the 18th November every year. This year in Norway, a seminar for health care providers about antibiotic use and resistance will be held, as well as several local events around ...

3Qs: The effect of antibiotic resistant bacteria

Oct 02, 2013

Last month, the Centers for Disease Control and Prevention released a report titled Antibiotic resistance threats in the United States, 2013, that served as a first-ever snapshot of the effect antibiotic ...

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

13 hours ago

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

verkle
3 / 5 (1) Jan 20, 2014
This is a health concern for everyone, even for those who dislike taking antibiotics. For diseases such as AIDS, a simple lifestyle change is the answer to not getting the disease nearly 100% of the time. For for these bacterial infections, even if you have never taken antibiotics your whole life, you would still be at risk with these drug-resistant strains that have developed.

Not good!

evelynkelly65
not rated yet Jan 20, 2014
Antibiotics are used in many health concerns and of course, without the antibiotics risk is common. These antibiotics are the most effective treatment for preventing any infection, whether it is skin infection, viral infection or bacterial infection, only antibiotics are provided. I am glad that I came across to your post and read this brilliant information. Thanks for the share and keep awaiting for more new posts.
ODesign
not rated yet Jan 20, 2014
Can anti-biotic resistant bugs be prevented in a capitalist determined resource allocation society? There's a communal harm/benefit cost part of antibiotic resistance that is not recognized or accounted for in our free market structure. Basically as long as people make antibiotics or use them in a private property based marketplace, then communal "externalities" are irrelevant in the risk reward calculations of individuals choosing their daily actions.
.
Basically it doesn't cost the doctors or medical professionals individually so they don't spend resources on preventing antibiotic resistance. This happens at a individual level and business level so the problem of antibacterial resistance simply does not factor into our ROI calculations. At a society and civilization scale we do care as a group, but that doesn't result in changes to activities of individuals for reasons tied to our economic policy decisions.